Metraipolis › archive › dc_7b00de4f6019

Efficacy and safety of the neoadjuvant chemoimmunotherapy with pembrolizumab plus docetaxel and cisplatin in resectable locally advanced squamous cell… — Europe PMC PMID:41479894

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41479894
DOI
10.3389/fimmu.2025.1664892
License (as archived)
solo-consultazione
Archived
2026-11-07T14:02:51.960Z
SHA-256 of the archived text
4b04f0904e04ebd2f32e62d5f98490a15755271dbeab1b5d08f0e8adae4059a4
Stable URL of this page
https://metraipolis.com/documento/dc_7b00de4f6019

How to cite

Efficacy and safety of the neoadjuvant chemoimmunotherapy with pembrolizumab plus docetaxel and cisplatin in resectable locally advanced squamous cell… — Europe PMC PMID:41479894 — Europe PMC (en), https://europepmc.org/article/MED/41479894 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7b00de4f6019 (Metraipolis archive dc_7b00de4f6019, sha256 4b04f0904e04ebd2f32e62d5f98490a15755271dbeab1b5d08f0e8adae4059a4)
BibTeX
@misc{dc7b00de4f6019,
  title = {Efficacy and safety of the neoadjuvant chemoimmunotherapy with pembrolizumab plus docetaxel and cisplatin in resectable locally advanced squamous cell… — Europe PMC PMID:41479894},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41479894},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7b00de4f6019; sha256 4b04f0904e04ebd2f32e62d5f98490a15755271dbeab1b5d08f0e8adae4059a4},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41479894. Agents can read the archived copy with the MCP tool read_document.